Clinical efficacy and safety of Cadonilimab in the treatment of advanced gynecological malignancies: a retrospective, real-world study

Clinical efficacy and safety of Cadonilimab in the treatment of advanced gynecological malignancies: a retrospective, real-world study

Abstract Background Cadonilimab, recognized as the most rapidly developed Chinese drug in the field of cervical cancer, received marketing approval in China in 2022. We conducted a study to investigate the safety and efficacy of Cadonilimab, combined with and without chemotherapy or bevacizumab trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Yisidan Huang, Yuting Zeng, Cui Zhang, Can Yang, Hanqun Zhang, Libo Li, Xiaoqing Luo, Yunchong Liu, Jiaying Bai, Fenghu Li, Yong Li
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Cancer
Subjects:
Cadonilimab
Gynecological Malignancies
Immunotherapy
Safety
Online Access:https://doi.org/10.1186/s12885-025-14603-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14603-0

Similar Items